Amalgamated Bank Sells 4,991 Shares of Colgate-Palmolive (NYSE:CL)

Amalgamated Bank cut its stake in shares of Colgate-Palmolive (NYSE:CL) by 2.7% in the 4th quarter, Holdings Channel.com reports. The fund owned 177,580 shares of the company’s stock after selling 4,991 shares during the period. Amalgamated Bank’s holdings in Colgate-Palmolive were worth $16,144,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of CL. FMR LLC lifted its holdings in shares of Colgate-Palmolive by 65.6% during the third quarter. FMR LLC now owns 6,749,275 shares of the company’s stock valued at $700,642,000 after purchasing an additional 2,674,807 shares in the last quarter. Barclays PLC increased its holdings in Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock worth $793,542,000 after buying an additional 2,132,747 shares in the last quarter. State Street Corp raised its position in Colgate-Palmolive by 3.8% in the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock worth $5,028,170,000 after buying an additional 1,784,411 shares during the last quarter. Nordea Investment Management AB lifted its stake in Colgate-Palmolive by 32.5% during the 4th quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company’s stock valued at $462,121,000 after acquiring an additional 1,247,731 shares during the period. Finally, AustralianSuper Pty Ltd boosted its holdings in shares of Colgate-Palmolive by 941.9% during the 4th quarter. AustralianSuper Pty Ltd now owns 1,138,655 shares of the company’s stock valued at $103,515,000 after acquiring an additional 1,029,364 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 2.5 %

Shares of CL opened at $92.36 on Wednesday. The business’s 50 day moving average is $88.86 and its 200 day moving average is $95.66. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 12-month low of $85.32 and a 12-month high of $109.30. The company has a market capitalization of $74.95 billion, a PE ratio of 26.24, a price-to-earnings-growth ratio of 4.20 and a beta of 0.44.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the firm earned $0.87 EPS. Research analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.17%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on CL shares. UBS Group decreased their price objective on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a report on Monday, February 3rd. Morgan Stanley cut their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. JPMorgan Chase & Co. lowered their target price on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a report on Monday, February 3rd. Royal Bank of Canada reissued a “sector perform” rating and issued a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Finally, Stifel Nicolaus reduced their price target on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Hold” and an average target price of $101.16.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.